{"filing":{"accession_number":"0001140361-26-037450","cik":"0000842023","ticker":"TECH","company_name":"BIO-TECHNE Corp","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-23","primary_document":"ef20082601_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/ef20082601_8k.htm"},"events":[{"id":34665,"run_id":31908,"accession_number":"0001140361-26-037450","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.97,"summary":"Bio-Techne shareholders voted on September 23, 2026 to approve the Merger Agreement with Merck KGaA, with 121,929,544 votes in favor and 1,208,817 against (78.55% quorum attendance). This shareholder approval of the material acquisition is highly material to investors.","company_name":"BIO-TECHNE Corp","ticker":"TECH","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38471,"accession_number":"0001140361-26-037450","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of a special shareholder meeting held on September 23, 2026, where Bio-Techne shareholders voted to approve the Merger Agreement with Merck KGaA. The filing reports final voting tallies: 121,929,544 votes for the Merger Agreement Proposal versus 1,208,817 against, with 78.55% quorum attendance. This is a classic shareholder vote result disclosure required under Item 5.07, and the approval of a material acquisition by shareholders is highly material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T21:09:48.357192+00:00","company_name":"","ticker":null,"filing_date":""},{"id":38472,"accession_number":"0001140361-26-037450","item_number":"7.01","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Bio-Techne disclosed the results of a Special Meeting of Shareholders held on September 23, 2026, where shareholders voted to approve the Merger Agreement under which Merck KGaA proposes to acquire Bio-Techne. The press release explicitly states \"Bio-Techne shareholders voted to approve and adopt the definitive agreement,\" which is a direct disclosure of shareholder vote results on a material acquisition proposal. This is a classic shareholder_vote_results event under Item 5.07, disclosed here via Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T21:09:48.357192+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38471,"accession_number":"0001140361-26-037450","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of a special shareholder meeting held on September 23, 2026, where Bio-Techne shareholders voted to approve the Merger Agreement with Merck KGaA. The filing reports final voting tallies: 121,929,544 votes for the Merger Agreement Proposal versus 1,208,817 against, with 78.55% quorum attendance. This is a classic shareholder vote result disclosure required under Item 5.07, and the approval of a material acquisition by shareholders is highly material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T21:09:48.357192+00:00","company_name":"BIO-TECHNE Corp","ticker":"TECH","filing_date":"2026-09-23"},{"id":38472,"accession_number":"0001140361-26-037450","item_number":"7.01","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Bio-Techne disclosed the results of a Special Meeting of Shareholders held on September 23, 2026, where shareholders voted to approve the Merger Agreement under which Merck KGaA proposes to acquire Bio-Techne. The press release explicitly states \"Bio-Techne shareholders voted to approve and adopt the definitive agreement,\" which is a direct disclosure of shareholder vote results on a material acquisition proposal. This is a classic shareholder_vote_results event under Item 5.07, disclosed here via Item 7.01 (Regulation FD Disclosure).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T21:09:48.357192+00:00","company_name":"BIO-TECHNE Corp","ticker":"TECH","filing_date":"2026-09-23"}]}